Clinical trial Recruiting at 1 site Interventional Ages 50 to 80

Increasing daily physical activity to slow cognitive decline in alpha-synuclein disorders

Official title: Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

Run by University Hospital, Bonn · NCT07324330 · Data updated 2026-11-12

This study will test whether using a motivational smartphone app to increase everyday physical activity can help slow cognitive decline in people aged 50–80 with isolated REM sleep behavior disorder (an early sign of alpha‑synuclein disease).

Quick facts

Study typeInterventional
Ages50 Years to 80 Years
SexAll
Enrollment130 (estimated)
SponsorUniversity Hospital, Bonn
Academic / other
Locations1 site (Bonn, North Rhine West-Falia)
StatusRecruiting
StartedDecember 4, 2025
Main results expectedDecember 1, 2028
Study endsDecember 1, 2029
Registry record updatedJanuary 16, 2026
Trial IDNCT07324330 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 50–80 with polysomnography-confirmed iRBD who average under 10,000 steps/day, have basic smartphone skills, and sufficient German language proficiency.

Probably not a fit

People with established Parkinson's disease or dementia, those already highly active (well above 10,000 steps/day), individuals unable to use the required smartphone, or non-German speakers are unlikely to benefit from this specific program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-blind, actively controlled intervention that aims to increase the volume and intensity of everyday physical activity over one year using a motivational smartphone application. Participants include people with polysomnography-confirmed isolated REM sleep behavior disorder (iRBD) and a low baseline activity level, plus healthy control participants for comparison. Cognitive function and activity levels will be tracked over time to see if increased movement preserves cognition. Recruitment and visits are conducted at the University Hospital Bonn, and participants must have basic smartphone skills and sufficient German language ability.

Why it matters

Potential benefit: If successful, the approach could slow or delay cognitive decline in people with iRBD and potentially postpone development of Parkinsonian or dementia symptoms.

How similar studies have gone: Exercise and increased physical activity have shown cognitive and motor benefits in Parkinson's and related conditions in prior studies, but randomized, smartphone-delivered activity interventions specifically in iRBD are limited and relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

iRBD:

* Age: 50-80 years
* Polysomnographically confirmed diagnosis of iRBD
* Maximum of 120 minutes of sports/outdoor activities per day
* Less than an average of 10,000 steps per day during the 4-week eligibility and baseline phase
* Basic smartphone skills
* Sufficient knowledge of German (native language, C1 or C2)
* Ownership of a suitable smartphone (minimum screen size 4.6 inches, Android version 9 or iOS version 15 or newer)
* Consent to be informed of any additional findings

Healthy controls:

* Age: 50-80 years
* Maximum of 120 minutes of sports/outdoor activities per day
* Less than an average of 10,000 steps per day during the 4-week eligibility and baseline phase
* Basic smartphone skills
* Sufficient knowledge of German (native language, C1 or C2)
* Ownership of a suitable smartphone (minimum screen size 4.6 inches, Android version 9 or iOS version 15 or newer)
* Consent to be informed of any additional findings

Exclusion Criteria:

iRBD:

* Relevant cardiovascular diseases
* Problems with dexterity or cognitive impairments that make it difficult to use a smartphone
* Cognitive impairments that limit the ability to make informed decisions and consent to participate in the study
* Ownership of one of the following devices: Huawei P8 Lite, Huawei P9 Lite, Xiaomi Mi 6, Huawei P20 Lite (FitBit is not compatible)

Healthy controls:

* Relevant cardiovascular diseases
* Problems with dexterity or cognitive impairments that make it difficult to use a smartphone
* Cognitive impairments that limit the ability to make informed decisions and consent to participate in the study
* Ownership of one of the following devices: Huawei P8 Lite, Huawei P9 Lite, Xiaomi Mi 6, Huawei P20 Lite (FitBit is not compatible)
* clinically diagnosed iRBD

Where it's running

  • University Hospital of Bonn
    Bonn, North Rhine West-Falia, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.